Biologically Active Substance – Page 31 – Talk Bio

Actionable Insights Powered by AI

Moderna Secures $176 Million BARDA Award for Bird Flu Vaccine Development

1 year ago talkbio0Tagged BARDA, development aspects, Influenza in Birds, Moderna, pandemic preparedness, RNA, Messenger, Vaccines

Moderna, BARDA, Bird Flu, Vaccine Development, mRNA Technology, Pandemic Preparedness

Alumis Completes IPO, Raising $250 Million for Inflammation and Immunology Research

1 year ago talkbio0Tagged Alumis, biotech, Dental Plaque, Immunology, Inflammation, Inhibitor, IPO, Psoriasis, TYK2 gene, Uveitis

Alumis, IPO, Inflammation, Immunology, Biotech, TYK2 Inhibitor, Plaque Psoriasis, Uveitis, Lupus

Ensho Therapeutics Launches with Phase 2-Ready Oral α4β7 Inhibitor for Inflammatory Bowel Disease